Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00562796 · ClinicalTrials.gov registry record
Prevalence and Cardiovascular Effects of Growth Hormone Deficiency in Abdominal Obesity
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 149
- Enrollment target
NCT00562796 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 149 participants.
The verdict
NCT00562796 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 149 participants
- Enrollment target
Study Summary
Obesity is one of the leading causes of cardiovascular-related diseases, including diabetes and heart disease. Obesity, and more specifically abdominal obesity, may cause decreased growth hormone (GH) levels. It is believed that GH deficiency may contribute to increased cardiovascular risk by affecting insulin resistance, inflammatory markers, and blood cholesterol levels. This study will determine the occurrence of GH deficiency in abdominal obesity and whether GH deficiency is associated with increased cardiovascular risk beyond traditional risk factors.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 149 participants |
| Start Date | 2007-11 |
| Est. Completion | 2011-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00562796
The ClinicalTrials.gov registry entry for NCT00562796 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 149 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00562796 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00562796 about?
NCT00562796 is a clinical study titled "Prevalence and Cardiovascular Effects of Growth Hormone Deficiency in Abdominal Obesity". Obesity is one of the leading causes of cardiovascular-related diseases, including diabetes and heart disease. Obesity, and more specifically abdominal obesity, may cause decreased growth hormone (GH) levels. It is believed that GH deficiency may contribute to increased cardiovascular risk by affect...
What is the current status of trial NCT00562796?
This trial is currently completed. The enrollment target is 149 participants. The study started on 2007-11. Estimated completion is 2011-05.
Who is sponsoring clinical trial NCT00562796?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.